NEWS

Lenoss Oversubscribes $4 Million Series A Financing

Funding will accelerate commercialization and fuel innovative product development

Read More

Slater Invests in Octagon Therapeutics Seed Round

Octagon is developing new medicines for autoimmune disease based on selective immunomodulation.

Read More

Bolden Announces $1.5M Pre-Seed Financing

Development of Antisense Oligonucleotides Seeks to Promote Neurogenesis.

Read More

Lenoss Medical: All Things OsteoPearl

Ingenuity lies in simplicity. Our Q&A with Lenoss Medical Founder & CEO, Dom Messerli

Read More

MindImmune Appoints Industry Leaders to Board

Brad Margus and Robert Michael Poole, MD FACP, bring deep background and experience

Read More

Slater to oversee $12M for Rhode Island venture development

Venture efforts will get $12 million in federal funding via a new agreement.

Read More

Brown-launched biotech secures $375,000 in Slater funding

XM Therapeutics seeks to develop new treatments for chronic heart and pulmonary conditions.

Read More

Slater Invests in XM Therapeutics from Brown University

Biotech targeting heart failure and pulmonary fibrosis comes out of stealth.

Read More

Thorne Sparkman at Brown Innovation Showcase

Faculty inventions, startups shine at Innovation@Brown Showcase

Business leaders, investors and entrepreneurs convened in Providence to connect with Brown scientists.

Read More

State of Innovation: R.I.’s ecosystem for entrepreneurs shows resilience

More entrepreneurs are launching companies and putting down roots in the Ocean State.

Read More

RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company

New Fund Participates in Series A Financing for URI-Based MindImmune, Developer of a Novel Treatment for Neuroinflammatory Conditions Such as Alzheimer’s Disease

Read More

Noted Scientist Nancy Ryan Gray and Brown University Engineering Dean Lawrence Larson Join the Slater Board

New appointees bring critical insight into the commercialization of university-based research.

Read More

There’s a New Implant Developed in Rhode Island to Treat Spine Fractures

Using special instrumentation these Osteo-Pearls are implanted into the fractured vertebrae.

Read More

RightHill Ventures Launches to Accelerate the Journey from Research to Startup for University Innovations

Beginning with innovations from Brown University researchers, new fund will build companies from university discoveries.

Read More

Arctura Awarded $1.15 Million Grant from U.S. Dept. of Energy

Arctura has won a $1.15-million grant from the U.S. Dept. of Energy to commercialize a new blade coating designed to reduce the damage to wind turbine blades caused by lightning.

Read More

Slater-Backed Company Acquired by Novartis

Cadent Therapeutics has entered into an agreement to be acquired by global healthcare giant Novartis [NYSE: NVS] in a deal worth up to $770 million. 

Read More

$597,500 in EDA Grants for Slater Technology Fund, RI Bio Will Boost Health Care Startups in Rhode Island

Federal grants will launch new partnership to support translational research companies and a program to grow life science startups.

Read More

Slater Technology Fund Establishes Its Third Special-Purpose Fund to Invest in HappyNest

HappyNest is a technology-enabled laundry pickup and delivery service expanding nationwide from its headquarters in Rhode Island.

Read More

Slater Technology Fund Invests in Pharmaceutical Startup Developing Novel Cancer Therapeutics

URI-based company is developing promising new synthetic molecules for use in treating ovarian cancer.

Read More

Slater Technology Fund Closes on $25,000 Investment in EdTech Startup

GoPeer is building a technology platform to streamline the effort and expense associated with K-12 tutoring.

Read More